US AUTHORITIES have seized 4.7 million unauthorised e-cigarettes valued at US$86.5 million in the largest operation of its kind to date, the Department of Health and Human Services said on Wednesday.
The seizures, led by the US Food and Drug Administration and US Customs and Border Protection, were part of a joint federal operation in Chicago aimed at intercepting illegal e-cigarette shipments, HHS said.
Big tobacco companies, campaigners and others have called on the agency to focus enforcement on distributors and middlemen that fuel the market for unauthorised e-cigarettes from US soil but have so far faced limited action from the FDA.
Most of the illegal shipments originated in China and included vague product descriptions and incorrect valuations to evade duties and safety reviews, HHS said.
“This enforcement action is part of the FDA’s broader aggressive strategy against childhood vaping,” HHS added.
In total this year, the FDA and CBP have blocked over 6 million unauthorised e-cigarettes worth more than US$120 million from entering the United States.
BT in your inbox
Start and end each day with the latest news stories and analyses delivered straight to your inbox.
Truth Initiative, a public health nonprofit group, said the actions were an important step in protecting youth but urged officials to “take further, sustained actions to cut off access to illegal e-cigarettes and ensure that retailers swiftly pull these products”.
At a press conference in Chicago earlier on Wednesday, US Attorney General Pam Bondi and US Health Secretary Robert F. Kennedy Jr. announced that the Department of Justice, HHS, FDA and other agencies had partnered to seize unauthorised vape products nationwide.
The conference was held outside Midwest Goods, a vape distributor targeted in the operation, where authorities seized US$14 million worth of vaping products.
SEE ALSO
Midwest Goods said in a statement that it was cooperating with authorities and would defend its rights in court if necessary.
The company added that the seized products had been on the market for years and were not challenged during a recent inspection by the FDA. REUTERS
